4.6 Article

Restrictive cardiomyopathy mutations demonstrate functions of the C-terminal end-segment of troponin I

Journal

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 552, Issue -, Pages 3-10

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2013.12.001

Keywords

Troponin I; C-terminal end-segment; Myofilament regulation; Restrictive cardiomyopathy; Striated muscle

Funding

  1. National Heart, Lung and Blood Institute and National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [HL098945, AR048816]
  2. Office of Vice President for Research, Wayne State University

Ask authors/readers for more resources

The C-terminal end-segment of Troponin I (TnI) corresponding to the last 27-33 amino acids is the most conserved structure of TnI and interacts with tropomyosin in a Ca2+-regulated manner, suggesting a role in muscle relaxation. Mutations in the C-terminal end-segment of cardiac TnI cause restrictive cardiomyopathy. Here we demonstrate that mouse cardiac TnI containing R193H or R205H mutation have significantly conformational changes in the region interfacing with troponin T (TnT) and increased binding affinity for TnT. These restrictive cardiomyopathy mutations also exhibit increased binding affinity for troponin Cat pCa 4. The effects of R193H mutation were more profound than that of R205H. Tertiary troponin complex was reconstituted using the TnI mutants and a mini TnT lacking tropomyosin-binding sites to examine the interaction between the C-terminal end-segment of TnI and tropomyosin. The results showed that, R193H, but not R205H, caused a moderate but statistically significant increase in the binding affinity for tropomyosin at pCa 9. Similar trend was observed at pCa 5.5 but not pCa 4. These results provide novel evidence for the function of the C-terminal end-segment of TnI, where mutations with conformational effects alter TnI's interaction with other troponin subunits and tropomyosin to cause diastolic dysfunction. (C) 2013 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available